SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent ...

Trial is evaluating ciforadenant as a potential first line therapy for metastatic renal cell cancer (RCC) in combination with ipilimumab (anti-CTLA-4) and nivolumab (anti-PD-1) Interim data shows ...

今天，小编要传授一些做PPT展示时最最实用的英文表达，教你如何变身presentation达人，勾住听众的心。 开场白 在正式场合做presentation，可能需要一些隆重点的开场白。 Ladies and gentleman. It's an honor to have the opportunity to address such a distinguished audience.

After upstaging Merck & Co.’s Keytruda as a monotherapy for patients with first-line non-small cell lung cancer (NSCLC) in ...

Updated interim results with an additional ~19 weeks of follow-up since the prior update [212Pb]VMT-α-NET continues to be well-tolerated Objective Response Rate of 44% (7 of 16 patients) in Cohort 2 ...

Details ExxonMobil Board’s Failure to Position the Company for Long-Term Value Creation in a Changing Industry and World Engine No. 1’s Nominees Have a Diverse Set of Experiences in Successful, Global ...

Forbes contributors publish independent expert analyses and insights. Mary Abbajay is a workplace expert who writes about succeeding at work. In today’s COVID-19 world, virtual meetings and ...

PJT Partners Inc . (NYSE:PJT), a premier global advisory-focused investment bank, presented its corporate overview on April 29, 2025, highlighting the firm’s growth trajectory, business model, and ...

This Friday, October 17, Paris Saint-Germain will face Strasbourg at the Parc des Princes (kick-off at 8:45 p.m., CET) for ...